Becker muscular dystrophy study
Clinical Trial – Becker muscular dystrophy study.
EDG-5506 was found to be well-tolerated without any serious adverse events reported.
angiotensin
Clinical Trial – New angiotensin II type 2 receptor agonist.
The drug is available orally with target engagement and anti-fibrotic effects in human fibrotic lung and kidney tissue.
therapy
Clinical Trial – Traumatic brain injury therapy.
The trial will evaluate multiple dose levels of AST-004 over six months at a clinical research site in Kistarcsa, Hungary.
achondroplasia
Clinical Trial – Phase II data of achondroplasia trial.
Voxzogo improved height Z-score by 0.30 SD and annualised growth velocity by 0.92cm/year versus placebo.
B-cell lymphoma
Clinical Trial – B-cell lymphoma new therapy trial.
The trial subjects had an overall response rate and complete response rate of 63% and 39%, respectively.
carcinoma
Clinical Trials – Data of adenoid cystic carcinoma therapy.
The trial will evaluate rivoceranib in 80 patients, including 53 based in the US.
Healthcare
Cohortias – Healthcare market in Brazil.
This is a best prospect industry sector for this country. Includes a market overview and trade data.
Monitoring
Cohortias – Clinical Trial Monitoring.
The responsibility of the clinical trial monitor is to ensure that the trial is being conducted in accordance with ICH GCP guidelines.
latin america
Cohortias – The research landscape of Latin America.
Analysts at the Institute for Scientific Information report on the research profiles of 34 countries in South and Central America, Mexico and the Caribbean.
breast cancer
Clinical Trial – Phase 1b/3 breast cancer therapy trial.
The trial will analyze the safety and efficacy of afuresertib plus fulvestrant combination in HR+/HER2- breast cancer patients.
